Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Dual Therapy vs Standard Triple Therapy for H. Pylori
NCT05342532Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jun 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin, omeprazole in Helicobacter pylori infection, sponsored by Icahn School of Medicine at Mount Sinai. Started Jun 2019; status: completed.
02
Drugs
amoxicillinomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05342532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05342532.